VEGFA and neoplasm: Thus, inhibiting the VEGF binding to its receptor either by neutralizing the ligand or the receptor by antibodies or direct inhibition of intracellular kinase domain through competing with the ATP-binding site is considered a very successful therapeutic strategy to halt tumor progress [27,29,30,31].